![](https://www.statnews.com/wp-content/uploads/2023/10/IMG_3071-768x432.jpg)
The Readout
Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Here’s our web archive of the free email newsletter delivered daily, Monday through Friday.
Latest
![](https://www.statnews.com/wp-content/uploads/2023/10/IMG_3071-768x432.jpg)
![](https://www.statnews.com/wp-content/uploads/2022/12/AdobeStock_169901679-768x432.jpeg)
STAT Plus: Vampiric cancer cells, a brain atlas, & alleged misconduct at Cassava
![](https://www.statnews.com/wp-content/uploads/2020/01/AP_16244655819170-768x432.jpg)
STAT Plus: Cell and gene therapies could be a safer bet than other drugs
![](https://www.statnews.com/wp-content/uploads/2022/06/GettyImages-73067942-768x432.jpg)
STAT Plus: With Ozempic, Wall Street moves on from a whole other class of medicines
![](https://www.statnews.com/wp-content/uploads/2023/04/AdobeStock_426527439-768x432.jpeg)
STAT Plus: Want a biotech buyout? Target cancer
![](https://www.statnews.com/wp-content/uploads/2023/02/AP22353823659091-768x432.jpg)
STAT Plus: NIH funds expanded access projects for ALS
![](https://www.statnews.com/wp-content/uploads/2021/10/GettyImages-1230726791-768x432.jpg)
Moderna’s plan to make a single vaccine for Covid, influenza, and RSV is on track
![](https://www.statnews.com/wp-content/uploads/2021/01/GettyImages-1229654314-768x432.jpg)